Gene and cell therapy: Therapeutic mechanisms and strategies/ (Record no. 162427)

MARC details
000 -LEADER
fixed length control field 00404nam a2200145Ia 4500
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780849387685
040 ## - CATALOGING SOURCE
Transcribing agency CUS
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.895
Item number TEM/G
245 #0 - TITLE STATEMENT
Title Gene and cell therapy: Therapeutic mechanisms and strategies/
Statement of responsibility, etc. edited by Nancy Smyth Templeton.
250 ## - EDITION STATEMENT
Edition statement 3rd ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Name of publisher, distributor, etc. CRC Press,
Date of publication, distribution, etc. 2008.
Place of publication, distribution, etc. Boca Raton:
300 ## - PHYSICAL DESCRIPTION
Extent xviii, 1120 p. :
Other physical details ill. ;
Dimensions 29 cm.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Part I Delivery Systems and Therapeutic Strategies <br/>1 Retroviral Vectors for Cell and Gene Therapy<br/>2 Production of Retroviral Vectors: From the Producer Cell to the Final Product<br/>3 Adenovirus Vectors for Gene Therapy<br/>4 Modified Adenoviruses for Gene Therapy<br/>5 Helper-Dependent Adenoviral Vectors for Gene Therapy<br/>6 Adeno-Associated Virus and AAV Vectors for Gene Delivery<br/>7 Therapeutic Gene Transfer with Replication-Defective Herpes Simplex Viral Vectors<br/>8 Glorioso Oncolytic Viruses for Treatment of Cancer<br/>9 Lentiviral Vectors<br/>10 Vaccinia Viral Vectors<br/>11 Baculovirus-Mediated Gene Transfer: An Emerging Universal Concept<br/>12 Bacterial Vector in Gene Therapy<br/>13 Redox-Responsive Polymer-Based Gene Delivery Systems<br/>14 Polymers and Dendrimers for Gene Delivery in Gene Therapy<br/>15 Receptor-Targeted Polyplexes for DNA and siRNA Delivery<br/>16 Electroporation of Plasmid-Based Vaccines and Therapeutics<br/>17 Magnetofection: Using Magnetic Particles and Magnetic Force to Enhance and to Target Nucleic Acid Deliver<br/>18 Biolistic and Other Needle-Free Delivery Systems<br/>19 Optimization of Nonviral Gene Therapeutics<br/>20 Photochemical Internalization: A Technology for Efficient and Site-Specific Gene Delivery<br/>21 Interactions in Macromolecular Complexes Used as Nonviral Vectors for Gene Delivery<br/><br/>Part II Other Therapeutic Strategies <br/>22 In vivo Applications of Morpholino Oligonucleotides<br/>23 Antisense Oligonucleotide-Based Therapeutics<br/>24 Development of RNAi Therapeutics<br/>25 Suicide Gene Therapy<br/>26 Selectable Markers for Gene Therapy<br/>27 Embryonic Stem Cells and Their Application in Regenerative Medicine and Tissue Engineering<br/>28 Polymeric Nano- and Microparticles for the Delivery of Antisense Oligonucleotides and siRNA<br/><br/>Part III Gene Expression and Detection <br/>29 Deliberate Regulation of Therapeutic Transgenes<br/>30 Monitoring Gene and Cell Therapies in Living Subjects with Molecular Imaging Technologies<br/>31 Nonviral Genome Modification Strategies for Gene Therapy: Transposon, Integrase, and Homologous Recombination Systems<br/><br/>Part IV Disease Targets and Therapeutic Strategies<br/>32 Hematopoietic Progenitor Cells<br/>33 Gene Therapy for Hematopoietic Disorders<br/>34 Use of Genetically Modified Stem Cells in Experimental Gene Therapies<br/>35 Cardiovascular Gene and Cell Therapy<br/>36 Gene Therapy for Cancer<br/>37 Molecular Therapy for Type 1 and Type 2 Diabetes<br/>38 Progress toward Gene Therapy for Cystic Fibrosis<br/>39 Gene Therapy for Neurological Diseases<br/>40 Principles of Gene Therapy for Inborn Errors of Metabolism<br/>41 RNA Interference-Based Gene Therapy Strategies for the Treatment of HIV Infection<br/>42 Cutaneous Gene Transfer: Cell and Gene Therapy of Skin and Systemic Disorders<br/>43 Gene Therapy for Childhood Onset Blindness<br/>44 DNA Vaccines<br/>45 Immunoisolation for CNS Cell Therapy<br/><br/>Part V Clinical Trials and Regulatory Issues<br/>46 Cardiovascular Gene Therapy<br/>47 Gene Therapy for the Treatment of Cancer: From Laboratory to Bedside<br/>48 p53 Tumor Suppressor Opens Gateways for Cancer Therapy<br/>49 Recombinant Adenoviral-p53 Agent for Treatment of Cancers<br/>50 Gene Marking Studies of Hematopoietic Cells<br/>51 Regulatory Aspects of Gene Therapy
650 ## - SUBJECT
Keyword Gene Therapy
650 ## - SUBJECT
Keyword Cellular Therapy
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name edited by Templeton, Nancy Smyth
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type General Books Science Library
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Full call number Accession number Date last seen Koha item type Public note
        Science Library, Sikkim University Science Library, Sikkim University Science Library General Section 29/08/2016 615.895 TEM/G P17313 16/01/2020 General Books Science Library Books For SU Science Library
SIKKIM UNIVERSITY
University Portal | Contact Librarian | Library Portal

Powered by Koha